Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment

Author:

Sottilotta Gianluca1ORCID,Mangano Carmelo2,Basile Rosa2,Falcone Carmela3,Luise Francesca4,Megalizzi Demetrio1,Nicolò Giovanna Maria5,Oriana Vincenzo1,Piromalli Angela4

Affiliation:

1. Hemophilia Centre, Grande Ospedale Metropolitano, Reggio Calabria, Italy

2. Infectious Disease Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy

3. Radiology Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy

4. Analysis Laboratory, Grande Ospedale Metropolitano, Reggio Calabria, Italy

5. Clinical Pathology, University of Catania, Catania, Italy

Abstract

Patients with COVID-19 are at high risk of thromboembolic events; for this reason, the use of heparin is largely recommended but, in addition to thrombotic complications, bleeding is a significant cause of morbidity in patients with COVID-19. Idiopathic iliopsoas hematoma is a very rarely described hemorrhagic complication in patients with COVID-19. We report here two cases of iliopsoas hematoma in male patients with COVID-19 and being treated with heparin.

Publisher

SAGE Publications

Subject

General Medicine

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3